
    
      The study aims to assess blood pressure and lipid levels, the use of lipid-lowering and
      antihypertensive drugs, and treatment compliance and adverse events in hypertensive
      outpatients of 30 hospitals of different levels, following them up for 1 and 3 months after
      treatment, respectively. The study would reveal the compliance of blood pressure and lipid
      levels in hypertensive patients under management of hospitals at different levels, and
      analyze factors affecting blood pressure or lipid levels associated with treatment
      compliance. Therefore, the study would provide clinical data from the real world for future
      prevention and control of CVD in China.
    
  